Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Drug Discovery
Overview
Conditions
Intellectual Property
Research
R&D Pipeline
Cobroxin
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Arthritis FoundationCobroxin

Cobroxin for Chronic Pain

Cobroxin is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

For additional information about Cobroxin, visit www.Cobroxin.com.

 
Quick Nav
Cobroxin for Chronic Pain
Nyloxin // Chronic Pain Relief

 

 
Recent News
 
December 19, 2011
Nutra Pharma Letter to Shareholders


November 30, 2011
Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain


October 28, 2011
Nutra Pharma CEO Interviewed by Wall Street Reporter


 
 
Announcements
Click here to learn more about Nyloxin, our over-the-counter treatment for moderate to severe chronic pain.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics